Inactive Instrument
Sector Signal Genetics Inc Nasdaq
Stocks
US8266401046
Biotechnology & Medical Research
|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 09-16 | Sling Therapeutics raises $123 million to advance thyroid eye disease drug | RE |
| 08-31 | Lilly to buy Merida Biosciences for up to $2.88 billion in autoimmune drug push | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +4.16% | -0.30% | +6.32% | +32.63% | +84.62% | +58.96% | +94.17% | +11.49% | - | 71.53B | |
| -0.19% | -1.01% | -5.41% | +7.82% | +18.14% | +38.55% | +83.85% | +232.47% | +5,478.39% | 60.12B | |
| -1.51% | +2.20% | -1.47% | +6.60% | +6.95% | +10.66% | +35.15% | -17.45% | +211.42% | 48.85B | |
| -0.05% | -0.46% | +2.71% | +39.10% | +19.27% | +48.77% | +36.65% | +10.68% | +240.06% | 44.28B | |
| +0.38% | +6.43% | -1.26% | +6.56% | +157.70% | +345.54% | +641.55% | +641.55% | - | 43.83B | |
| +0.18% | -0.58% | -0.22% | +26.19% | +20.45% | +9.95% | +103.45% | +1.21% | +1,131.29% | 41.53B | |
| -0.67% | -0.45% | -6.82% | -0.84% | +3.09% | +4.47% | +46.37% | -17.19% | +134.15% | 30.13B | |
| +4.77% | +6.46% | +10.66% | +58.87% | +78.28% | +41.54% | +22.78% | -55.45% | - | 27.98B | |
| -1.29% | -5.53% | -3.71% | +8.97% | -34.42% | -19.42% | +352.04% | +335.15% | +718.79% | 25.25B | |
| -0.27% | -2.55% | -3.70% | +4.29% | +3.26% | +0.20% | -9.52% | -64.57% | - | 24.76B | |
| +1.12% | +2.81% | +8.67% | +36.34% | +15.59% | +27.89% | -6.58% | -14.02% | +107.71% | 20.99B | |
| +0.33% | -0.95% | +3.92% | +16.73% | +11.13% | +24.65% | +157.79% | +232.61% | +2,054.57% | 17.36B | |
| +1.67% | +4.74% | -21.36% | +6.12% | +186.76% | +163.24% | +345.14% | +1,419.98% | +651.59% | 15.54B | |
| -1.57% | -5.02% | +3.65% | +10.00% | +20.19% | +23.36% | +40.19% | -32.19% | +85.57% | 14.99B | |
| -0.11% | -4.10% | -8.10% | -13.60% | - | - | - | - | - | 14.98B | |
| -0.82% | +6.10% | +27.89% | +40.46% | +38.70% | +4.24% | - | - | - | 14.9B | |
| -0.41% | +0.45% | +7.27% | +7.61% | +33.26% | +43.97% | +167.32% | +183.13% | +375.65% | 14.53B | |
| +2.96% | -0.65% | -5.34% | +11.80% | +24.17% | -1.74% | +535.77% | - | - | 14.41B | |
| -0.32% | +3.47% | +1.20% | +30.78% | +47.89% | +100.70% | +50.53% | -30.27% | +257.41% | 14.13B | |
| Average | +0.47% | +0.41% | +0.78% | +17.71% | +40.84% | +51.42% | +158.63% | +177.32% | +953.89% | 29.48B | |
| Weighted average by Cap. | +0.66% | +0.51% | +0.59% | +18.93% | +42.93% | +57.94% | +146.45% | +145.29% | +1,374.57% |
- Stock Market
- Stocks
- VRDN Stock
- Stock
- Sector Signal Genetics Inc
Select your edition
All financial news and data tailored to specific country editions
